Biogen Inc.
BIIB | NASDAQ
$248.81
-$4.81 (-1.90%)
Nov 2, 2026, 1:41 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 19.89 | 13.65 | 32.27 | 13.21 | 22.98 | 9.85 |
PEG Ratio | -0.95 | 0.34 | -0.52 | 0.13 | -0.40 | -0.47 |
PS Ratio | 2.63 | 2.30 | 3.81 | 3.96 | 3.26 | 2.93 |
PB Ratio | 1.41 | 1.33 | 2.53 | 3 | 3.28 | 3.68 |
P/FCF Ratio | 12.59 | 8.86 | 30.30 | 35.17 | 10.58 | 10.35 |
P/OCF Ratio | 11.71 | 7.75 | 24.20 | 29.07 | 9.83 | 9.31 |
OCF/S Ratio | 22.47 | 29.72 | 15.73 | 13.61 | 33.15 | 31.46 |
Debt / Equity Ratio | 0.38 | 0.40 | 0.50 | 0.49 | 0.70 | 0.73 |
Quick Ratio | 2.03 | 0.90 | 1.26 | 2.58 | 1.51 | 1.55 |
Current Ratio | 2.68 | 1.35 | 2 | 2.99 | 1.83 | 1.84 |
Asset Turnover | 0.33 | 0.34 | 0.37 | 0.41 | 0.46 | 0.55 |
Interest Coverage | 7.63 | 9.95 | 8.49 | 11.72 | 11.01 | 20.64 |
Return on Equity | 7.08% | 9.76% | 7.85% | 22.74% | 14.28% | 37.39% |
Return on Assets | 4.39% | 5.82% | 4.33% | 12.41% | 6.52% | 16.25% |
Return on Invested Capital | 6.62% | 8.79% | 7.97% | 11.19% | 13.16% | 17.68% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 70.47% | 76.12% | 74.24% | 77.61% | 80.79% | 86.57% |
Net Profit Margin | 13.18% | 16.87% | 11.81% | 29.95% | 14.17% | 29.76% |
Pretax Profit Margin | 14.29% | 19.70% | 13.18% | 35.33% | 16.21% | 37.58% |
Operating Profit Margin | 19.14% | 25.74% | 21.32% | 28.40% | 25.42% | 34.16% |
FCF Margin | 20.90% | 26% | 12.56% | 11.24% | 30.79% | 28.30% |
EBITDA Margin | 30.02% | 30.96% | 24.17% | 34.77% | 35.73% | 38% |
Add to Watchlist
Select watchlists to add or remove BIIB